Gender differences in adiponectin levels and body composition in older adults: Hallym aging study

BMC Geriatrics

Volumn 14, Issue 1, 2014, Pages

  Song, Hong Ji ^a   Oh, Sohee ^b   Quan, Shanai ^a,c   Ryu, Ohk Hyun ^a   Jeong, Jin Young ^d   Hong, Kyung Soon ^a   Kim, Dong Hyun ^a,c  

^a Hallym University   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Hallym Research Institute of Clinical Epidemiology   (South Korea)

^d Korea Health Promotion Foundation   (South Korea)

Author keywords

Adiponectin; Ageing; Body composition; Gender difference; Older adults

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER;

AGED; AGING; ARTICLE; BLOOD; BODY COMPOSITION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROSPECTIVE STUDY; SEXUAL DEVELOPMENT; SOUTH KOREA; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BODY COMPOSITION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SEX CHARACTERISTICS;

EID: 84892764150     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-14-8     Document Type: Article

References (37)

1. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Li S, Shin HJ, Ding EL, van Dam RM, JAMA 2009 302 2 179 188 10.1001/jama.2009.976 19584347
2. Adiponectin: more than just another fat cell hormone? Chandran M, Phillips SA, Ciaraldi T, Henry RR, Diabetes Care 2003 26 8 2442 2450 10.2337/diacare.26.8.2442 12882876 (Pubitemid 36993340)
3. Epidemiologic evidence on serum adiponectin level and lipid profile. Izadi V, Farabad E, Azadbakht L, Int J Prev Med 2013 4 2 133 140 23543874
4. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikainen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, et al. PLoS Genet 2012 8 3 1002607 10.1371/journal.pgen. 1002607 22479202
5. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Gable DR, Hurel SJ, Humphries SE, Atherosclerosis 2006 188 2 231 244 16581078 (Pubitemid 44301148)
6. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y, Biochem Biophys Res Commun 1999 257 1 79 83 10.1006/bbrc.1999.0255 10092513 (Pubitemid 29299050)
7. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM, J Clin Endocrinol Metab 2001 86 8 3815 3819 10.1210/jcem.86.8.7741 11502817 (Pubitemid 32755982)
8. Plasma adiponectin levels and risk of myocardial infarction in men. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB, JAMA 2004 291 14 1730 1737 10.1001/jama.291.14.1730 15082700 (Pubitemid 38489895)
9. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH, Circulation 2006 114 7 623 629 10.1161/ CIRCULATIONAHA.106.618918 16894037 (Pubitemid 44252303)
10. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Wannamethee SG, Whincup PH, Lennon L, Sattar N, Arch Intern Med 2007 167 14 1510 1517 10.1001/archinte.167. 14.1510 17646605 (Pubitemid 47124181)
11. Adiposity, adipokines, and risk of incident stroke in older men. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N, Stroke 2013 44 1 3 8 10.1161/STROKEAHA.112.670331 23192755
12. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Kizer JR, Benkeser D, Arnold AM, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, Defilippi CR, Newman AB, Djousse L, Circulation 2012 126 25 2951 2961 10.1161/CIRCULATIONAHA.112.135202 23159554
13. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Wannamethee SG, Welsh P, Whincup PH, Sawar N, Thomas MC, Gudnarsson V, Sattar N, Eur J Cardiovasc Prev Rehabil 2011 18 1 65 71 20505514
14. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. Smith JD, Borel AL, Nazare JA, Haffner SM, Balkau B, Ross R, Massien C, Almeras N, Despres JP, J Clin Endocrinol Metab 2012 97 5 1517 1525 10.1210/jc.2011-2550 22337910
15. Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Arsenault BJ, Cartier A, Cote M, Lemieux I, Tremblay A, Bouchard C, Perusse L, Despres JP, Am J Cardiol 2009 104 2 240 246 10.1016/j.amjcard.2009.03.027 19576354
16. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA, J Clin Endocrinol Metab 2010 95 12 5419 5426 10.1210/jc.2010-1378 20843952
17. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Demerath EW, Reed D, Rogers N, Sun SS, Lee M, Choh AC, Couch W, Czerwinski SA, Chumlea WC, Siervogel RM, Towne B, Am J Clin Nutr 2008 88 5 1263 1271 18996861
18. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. Srikanthan P, Karlamangla AS, J Clin Endocrinol Metab 2011 96 9 2898 2903 10.1210/jc.2011-0435 21778224
19. The estimation of cardiovascular risk factors by body mass index and body fat percentage in Korean male adults. Cho YG, Song HJ, Kim JM, Park KH, Paek YJ, Cho JJ, Caterson I, Kang JG, Metabolism 2009 58 6 765 771 10.1016/j.metabol.2009.01.004 19446112
20. Body composition changes with aging: the cause or the result of alterations in metabolic rate and macronutrient oxidation? St-Onge MP, Gallagher D, Nutrition 2010 26 2 152 155 10.1016/j.nut.2009.07.004 20004080
21. The relationship between smoking. Socioeconomic status and grip strength among community-dwelling elderly men in Korea: Hallym aging study. Quan S, Jeong JY, Kim DH, Epidemiol Health 2013 35 2013001 23440903
22. Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study. Oh H, Quan SA, Jeong JY, Jang SN, Lee JE, Kim DH, PLoS One 2013 8 3 59071 10.1371/journal.pone. 0059071 23536858
23. Relationship between ED and depression among middle-aged and elderly men in Korea: Hallym aging study. Jeong JY, Lee SK, Kang YW, Jang SN, Choi YJ, Kim DH, Int J Impot Res 2011 23 5 227 234 10.1038/ijir.2011.32 21716296
24. The relationship between body fat mass and erectile dysfunction in Korean men: Hallym aging study. Cho YG, Song HJ, Lee SK, Jang SN, Jeong JY, Choi YH, Hong KS, Choi MG, Kang SH, Kang JH, Kim DH, Caterson I, Int J Impot Res 2009 21 3 179 186 10.1038/ijir.2009.8 19242481
25. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 6 461 470 10.7326/0003-4819-130-6-199903160-00002 10075613 (Pubitemid 29135798)
26. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology Collaboration, Ann Intern Med 2006 145 4 247 254 10.7326/0003-4819-145-4-200608150-00004 16908915 (Pubitemid 46768608)
27. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P, Arterioscler Thromb Vasc Biol 2008 28 6 1039 1049 10.1161/ATVBAHA.107.159228 18356555
28. Adiponectin is associated with low bone mineral density in elderly men. Basurto L, Galvan R, Cordova N, Saucedo R, Vargas C, Campos S, Halley E, Avelar F, Zarate A, Eur J Endocrinol 2009 160 2 289 293 19039084
29. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE, Diabetologia 2003 46 4 459 469 12687327 (Pubitemid 36577787)
30. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Laughlin GA, Barrett-Connor E, May S, Langenberg C, Am J Epidemiol 2007 165 2 164 174 17101706 (Pubitemid 46096378)
31. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC, Goulis DG, Metabolism 2013 62 4 457 478 10.1016/j.metabol.2012.08. 012 22999785
32. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Laughlin GA, Barrett-Connor E, May S, Int J Obes (Lond) 2007 31 3 457 465 10.1038/sj.ijo.0803427 16819528
33. Association of circulating adiponectin with testosterone in women during the menopausal transition. Matsui S, Yasui T, Tani A, Kato T, Kunimi K, Uemura H, Kuwahara A, Matsuzaki T, Irahara M, Maturitas 2012 73 3 255 260 10.1016/j.maturitas.2012.08.003 22939588
34. Influence of sex hormones on adiponectin expression in human adipocytes. Horenburg S, Fischer-Posovszky P, Debatin KM, Wabitsch M, Horm Metab Res 2008 40 11 779 786 10.1055/s-0028-1083780 18792884 (Pubitemid 352772691)
35. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. Kizer JR, Benkeser D, Arnold AM, Djousse L, Zieman SJ, Mukamal KJ, Tracy RP, Mantzoros CS, Siscovick DS, Gottdiener JS, Ix JH, J Clin Endocrinol Metab 2013 98 1 255 263 10.1210/jc.2012-2103 23162097
36. Sex differences in the association of adiponectin and low-grade inflammation with changes in the body mass index from youth to middle age. Ahonen T, Vanhala M, Kautiainen H, Kumpusalo E, Saltevo J, Gend Med 2012 9 1 1 8 10.1016/j.genm.2012.01.002 22333520
37. Ghrelin, adiponectin, and leptin do not predict long-term changes in weight and body mass index in older adults: longitudinal analysis of the Rancho Bernardo cohort. Langenberg C, Bergstrom J, Laughlin GA, Barrett-Connor E, Am J Epidemiol 2005 162 12 1189 1197 10.1093/aje/kwi338 16236994 (Pubitemid 41785913)